Motif Neurotech Appoints Steven Goetz as Chief Technology Officer

Motif Neurotech announced the appointment of Steven Goetz as Chief Technology Officer. Steven joins Motif after more than 26 years in the Neuromodulation Operating Unit at Medtronic, where, most recently, he served as Vice President of Technology and Platform Innovation. Steven will be responsible for leading all research and development (R&D) activities, including advancing Motif’s innovative therapeutic device for treatment resistant depression (TRD) and extending the company’s platform technology towards application to a broad set of mental health disorders.

Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.